Literature DB >> 549256

Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration.

T H LeJemtel, E C Keung, W J Schwartz, C S Maskin, M A Greenberg, R S Davis, R Forman, H S Ribner, E H Sonnenblick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 549256

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  6 in total

1.  Side effects of amrinone therapy.

Authors:  T H LeJemtel
Journal:  Br Heart J       Date:  1983-11

2.  Amrinone--promising innovation for treatment of the failing heart.

Authors:  R Hayward
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

3.  Amrinone before termination of cardiopulmonary bypass: haemodynamic variables and oxygen utilization in the postbypass period.

Authors:  J G Ramsay; J M DeJesus; J E Wynands; F E Ralley; J P O'Connor; G R Robbins; J Bilodeau
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

Review 4.  Amrinone. A preliminary review of its pharmacological properties and therapeutic use.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

5.  Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.

Authors:  P T Wilmshurst; D S Thompson; S M Juul; B S Jenkins; D J Coltart; M M Webb-Peploe
Journal:  Br Heart J       Date:  1984-07

6.  Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.

Authors:  J Bayliss; M Norell; R Canepa-Anson; S R Reuben; P A Poole-Wilson; G C Sutton
Journal:  Br Heart J       Date:  1983-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.